Recently, it was demonstrated that CASC2 in colorectal cancer is functioning as ceRNA for miR-18a, thereby modulating the expression of target gene PIAS3, and subsequently inhibiting CRC cell proliferation and tumor growth [14]. Here, PIAS3 is linked to colorectal carcinoma.